Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The gut metagenomics and metabolomics signature in patients with inflammatory bowel disease
Xinwei Xu, Dickson Kofi Wiredu Ocansey, Sanhua Hang, et al.
Gut Pathogens (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

The diagnostic and prognostic potential of gut bacteria in inflammatory bowel disease
Dickson Kofi Wiredu Ocansey, Sanhua Hang, Xinyi Yuan, et al.
Gut Microbes (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 39
Bacterial membrane vesicles in the pathogenesis and treatment of inflammatory bowel disease
Chinasa Valerie Olovo, Dickson Kofi Wiredu Ocansey, Ying Ji, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 9
Novel approaches in IBD therapy: targeting the gut microbiota-bile acid axis
Yinping Pan, Haojie Zhang, Minghui Li, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 9
The emerging role of the gut microbiota and its application in inflammatory bowel disease
Wang Xiu, Jianhua Peng, Pei-Pei Cai, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 179, pp. 117302-117302
Open Access | Times Cited: 9
An integrative multi-omic analysis defines gut microbiota, mycobiota, and metabolic fingerprints in ulcerative colitis patients
Matteo Scanu, Francesca Toto, Valentina Petito, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 6
Macronutrient balance determines the human gut microbiome eubiosis: insights from in vitro gastrointestinal digestion and fermentation of eight pulse species
Da Bin Lee, In‐Chang Hwang
Frontiers in Microbiology (2025) Vol. 15
Open Access
Integrating Biological Domain Knowledge with Machine Learning for Identifying Colorectal-Cancer-Associated Microbial Enzymes in Metagenomic Data
Burcu Bakır-Güngör, Nur Şebnem Ersöz, Malik Yousef
Applied Sciences (2025) Vol. 15, Iss. 6, pp. 2940-2940
Open Access
Resveratrol alleviates DSS-induced IBD in mice by regulating the intestinal microbiota-macrophage-arginine metabolism axis
Xinwei Xu, Dickson Kofi Wiredu Ocansey, Bing Pei, et al.
European journal of medical research (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 14
Role of glycolysis in inflammatory bowel disease and its associated colorectal cancer
Yuxuan Xia, Zhang Li, Dickson Kofi Wiredu Ocansey, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 12
Integrated 16S rRNA sequencing and metagenomics insights into microbial dysbiosis and distinct virulence factors in inflammatory bowel disease
Haijing Wang, Yuanjun Wang, Libin Yang, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 4
Therapeutic Prospects of Mesenchymal Stem Cell and Their Derived Exosomes in the Regulation of the Gut Microbiota in Inflammatory Bowel Disease
Yaru Qiao, Xiaohua Tang, Ziyue Liu, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 5, pp. 607-607
Open Access | Times Cited: 4
Probiotics Bifidobacterium lactis M8 and Lactobacillus rhamnosus M9 prevent high blood pressure via modulating the gut microbiota composition and host metabolic products
Yong Zhang, Tingting Zheng, Da Ma, et al.
mSystems (2023) Vol. 8, Iss. 6
Open Access | Times Cited: 11
Systematic review of metabolomic alterations in ulcerative colitis: unveiling key metabolic signatures and pathways
Meiling Liu, Siyi Guo, Liang Wang
Therapeutic Advances in Gastroenterology (2024) Vol. 17
Open Access | Times Cited: 3
Alterations of the Gut Microbiome and TMAO Levels in Patients with Ulcerative Colitis
Yelena Laryushina, Nadezhda Samoilova-Bedych, Lyudmila Turgunova, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 19, pp. 5794-5794
Open Access | Times Cited: 3
Farnesoid-X receptor as a therapeutic target for inflammatory bowel disease and colorectal cancer
Mengjiao Zhou, Danfeng Wang, Xiang Li, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 17
Effect of a Probiotic Beverage Enriched with Cricket Proteins on the Gut Microbiota: Composition of Gut and Correlation with Nutritional Parameters
Chaima Dridi, Mathieu Millette, Stéphane Salmieri, et al.
Foods (2024) Vol. 13, Iss. 2, pp. 204-204
Open Access | Times Cited: 2
Krill Oil and Its Bioactive Components as a Potential Therapy for Inflammatory Bowel Disease: Insights from In Vivo and In Vitro Studies
Yingying Liu, Ainsley M. Robinson, Xiao Su, et al.
Biomolecules (2024) Vol. 14, Iss. 4, pp. 447-447
Open Access | Times Cited: 2
Inflammation alters the expression pattern of drug transporters during Caco‐2 cell stimulation and azoxymethane‐induced colon tumorigenesis
Sherien M. El‐Daly, Shaimaa A. Gouhar, Sahar S. Abdelrahman
Journal of Biochemical and Molecular Toxicology (2024) Vol. 38, Iss. 9
Open Access | Times Cited: 2
The Microbiota-Dependent Worsening Effects of Melatonin on Gut Inflammation
Jefferson Luiz da Silva, Lia Vezenfard Barbosa, Camila Figueiredo Pinzan, et al.
Microorganisms (2023) Vol. 11, Iss. 2, pp. 460-460
Open Access | Times Cited: 6
Farnesoid X Receptor Agonists: A Promising Therapeutic Strategy for Gastrointestinal Diseases
Mohammad Almeqdadi, Fredric D. Gordon
Gastro Hep Advances (2023) Vol. 3, Iss. 3, pp. 344-352
Open Access | Times Cited: 6
Protective properties of Ophiopogonin D in DSS-induced colitis: insights into microbiota modulation
Tao Zhang, Zhiguo Guo, Xianhui Cheng, et al.
Inflammopharmacology (2024) Vol. 32, Iss. 5, pp. 3553-3570
Closed Access | Times Cited: 1
Gut Microbiome as a Target of Intervention in Inflammatory Bowel Disease Pathogenesis and Therapy
‏Helal F. Hetta, Yasmin N. Ramadan, Ahmad A. Alharbi, et al.
Immuno (2024) Vol. 4, Iss. 4, pp. 400-425
Open Access | Times Cited: 1
Acupuncture and Moxibustion for Inflammatory Bowel Disease: Regulatory Mechanisms Revealed by Microbiome and Metabolomic Analysis
Xinyue Yang, Min He, Jiazhen Cao, et al.
The American Journal of Chinese Medicine (2024), pp. 1-33
Closed Access | Times Cited: 1
Intestinal microecology-based treatment for inflammatory bowel disease: Progress and prospects
Xia-Xiao Yan, Wu Dong
World Journal of Clinical Cases (2023) Vol. 11, Iss. 1, pp. 47-56
Open Access | Times Cited: 3
Results and lessons learned from the sbv IMPROVER metagenomics diagnostics for inflammatory bowel disease challenge
Lusine Khachatryan, Yang Xiang, A. B. Ivanov, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top